Clinical Trial Update: Lecanemab for Early Onset Familial Alzheimer's Disease

View source ↗

Summary

A clinical trial is recruiting to evaluate lecanemab for early-onset familial Alzheimer's disease, sponsored by RenJi Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Early-onset Familial Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

Sponsor: RenJi Hospital | Conditions: Alzheimer Disease | Status: RECRUITING